# Phase I Multiple Ascending Dose Study for AZD 7268 in Healthy Volunteers

> **NCT00861718** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 40 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** AZD7268
- **DRUG:** AZD7268
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00861718
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** —
- **Final completion:** 2009-10
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2009-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00861718

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00861718, "Phase I Multiple Ascending Dose Study for AZD 7268 in Healthy Volunteers". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00861718. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*